| Mechanisms of multidrug resistance in cancer chemotherapy K Bukowski, M Kciuk, R Kontek International journal of molecular sciences 21 (9), 3233, 2020 | 1433 | 2020 |
| Doxorubicin—an agent with multiple mechanisms of anticancer activity M Kciuk, A Gielecińska, S Mujwar, D Kołat, Ż Kałuzińska-Kołat, I Celik, ... Cells 12 (4), 659, 2023 | 284 | 2023 |
| Irinotecan—still an important player in cancer chemotherapy: a comprehensive overview M Kciuk, B Marciniak, R Kontek International journal of molecular sciences 21 (14), 4919, 2020 | 200 | 2020 |
| Focus on UV-induced DNA damage and repair—disease relevance and protective strategies M Kciuk, B Marciniak, M Mojzych, R Kontek International journal of molecular sciences 21 (19), 7264, 2020 | 105 | 2020 |
| Metastasis and MAPK pathways M Kciuk, A Gielecińska, A Budzinska, M Mojzych, R Kontek International journal of molecular sciences 23 (7), 3847, 2022 | 99 | 2022 |
| Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies M Kciuk, A Gielecińska, S Mujwar, M Mojzych, B Marciniak, R Drozda, ... Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1), 1278-1298, 2022 | 76 | 2022 |
| Cyclin-dependent kinases in DNA damage response M Kciuk, A Gielecińska, S Mujwar, M Mojzych, R Kontek Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1877 (3), 188716, 2022 | 73 | 2022 |
| Recent advances in molecular mechanisms of cancer immunotherapy M Kciuk, EB Yahya, M Mohamed Ibrahim Mohamed, S Rashid, MO Iqbal, ... Cancers 15 (10), 2721, 2023 | 47 | 2023 |
| Discovery of adapalene and dihydrotachysterol as antiviral agents for the Omicron variant of SARS-CoV-2 through computational drug repurposing O Fidan, S Mujwar, M Kciuk Molecular diversity 27 (1), 463-475, 2023 | 39 | 2023 |
| Preparation of Novel Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides and Their Experimental and Computational Biological Studies M Kciuk, S Mujwar, A Szymanowska, B Marciniak, K Bukowski, M Mojzych, ... International Journal of Molecular Sciences 23 (11), 5892, 2022 | 39 | 2022 |
| Epigallocatechin-3-gallate therapeutic potential in cancer: mechanism of action and clinical implications M Kciuk, M Alam, N Ali, S Rashid, P Głowacka, R Sundaraj, I Celik, ... Molecules 28 (13), 5246, 2023 | 37 | 2023 |
| Substances of natural origin in medicine: Plants vs. cancer A Gielecińska, M Kciuk, S Mujwar, I Celik, D Kołat, Ż Kałuzińska-Kołat, ... Cells 12 (7), 986, 2023 | 35 | 2023 |
| Computational bioprospecting guggulsterone against ADP ribose phosphatase of SARS-CoV-2 M Kciuk, S Mujwar, I Rani, K Munjal, A Gielecińska, R Kontek, K Shah Molecules 27 (23), 8287, 2022 | 30 | 2022 |
| Review of the Synthesis and Anticancer Properties of Pyrazolo[4,3-e][1,2,4]triazine Derivatives Z Bernat, A Szymanowska, M Kciuk, K Kotwica-Mojzych, M Mojzych Molecules 25 (17), 3948, 2020 | 30 | 2020 |
| Apoptosis, necroptosis, and pyroptosis as alternative cell death pathways induced by chemotherapeutic agents? A Gielecińska, M Kciuk, EB Yahya, T Ainane, S Mujwar, R Kontek Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 189024, 2023 | 23 | 2023 |
| PD-1/PD-L1 and DNA damage response in cancer M Kciuk, D Kołat, Ż Kałuzińska-Kołat, M Gawrysiak, R Drozda, I Celik, ... Cells 12 (4), 530, 2023 | 20 | 2023 |
| Insights into the role of LncRNAs and miRNAs in glioma progression and their potential as novel therapeutic targets M Kciuk, EB Yahya, MMI Mohamed, MA Abdulsamad, AA Allaq, ... Cancers 15 (13), 3298, 2023 | 19 | 2023 |
| Gieleci nska M Kciuk, M Malinowska Molecules 28, 7230, 2023 | 19 | 2023 |
| Advances in DNA repair—emerging players in the arena of eukaryotic DNA repair M Kciuk, K Bukowski, B Marciniak, R Kontek International Journal of Molecular Sciences 21 (11), 3934, 2020 | 17 | 2020 |
| Cancer-associated transcription factors in DNA damage response M Kciuk, A Gielecińska, D Kołat, Ż Kałuzińska, R Kontek Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1877 (4), 188757, 2022 | 16 | 2022 |
